Viking Therapeutics: A High Potential Biotech Play With Manageable Risks

Viking Therapeutics (NASDAQ: VKTX ) is a reasonably de-risked high potential play in obesity treatments. The play is de-risked because early vetting of endocrine and metabolic therapeutics is positive. Although biotechnology bets are subject to binary outcomes, sometimes even as late asI am a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management. My focus is on equity valuation, market trends, and portfolio optimization to uncover high-growth invest ...